Jurriën M. ten Berg

Research interests

Publications

• 2024 ESC Guidelines for the management of chronic coronary syndromes

  European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae177

• 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

  European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae176

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac244

• Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

  Nature Reviews Cardiology · 2022 · https://doi.org/10.1038/s41569-021-00665-7

• 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac270

• Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

  New England Journal of Medicine · 2020 · 10.1056/nejmoa2017815

• Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

  The Lancet · 2020 · 10.1016/s0140-6736(20)30325-1

• A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1907096

• Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

  JACC: Cardiovascular Interventions · 2019 · 10.1016/j.jcin.2019.03.034

• Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1708454

• ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

  European Heart Journal · 2015 · 10.1093/eurheartj/ehu523

• Bleeding and stent thrombosis on P2Y 12 -inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

  European Heart Journal · 2015 · 10.1093/eurheartj/ehv104

• Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1415098

• 2014 ESC/EACTS Guidelines on myocardial revascularization

  European Journal of Cardio-Thoracic Surgery · 2014 · https://doi.org/10.1093/ejcts/ezu366

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

  European Heart Journal · 2014 · 10.1093/eurheartj/ehu298

• Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.07.101

• Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1308075

• Bivalirudin Started during Emergency Transport for Primary PCI

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1311096

• Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(12)62177-1

• Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention

  Journal of the American College of Cardiology · 2011 · 10.1016/j.jacc.2011.06.059

• Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

  JAMA · 2010 · 10.1001/jama.2010.181

• Paraoxonase-1 is a major determinant of clopidogrel efficacy

  Nature Medicine · 2010 · 10.1038/nm.2281

• Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

  European Heart Journal · 2010 · https://doi.org/10.1093/eurheartj/ehq449

• Predictors of Coronary Stent Thrombosis

  Journal of the American College of Cardiology · 2009 · 10.1016/j.jacc.2008.12.055

• Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

  The Lancet · 2008 · 10.1016/s0140-6736(08)61235-0

• A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel

  New England Journal of Medicine · 2004 · 10.1056/nejmoa031859

Current projects

No projects listed.